======= BCAT1 =======
== Gene Information ==
* **Official Symbol**: BCAT1
* **Official Name**: branched chain amino acid transaminase 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=586|586]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P54687|P54687]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=BCAT1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BCAT1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/113520|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes the cytosolic form of the enzyme branched-chain amino acid transaminase. This enzyme catalyzes the reversible transamination of branched-chain alpha-keto acids to branched-chain L-amino acids essential for cell growth. Two different clinical disorders have been attributed to a defect of branched-chain amino acid transamination: hypervalinemia and hyperleucine-isoleucinemia. As there is also a gene encoding a mitochondrial form of this enzyme, mutations in either gene may contribute to these disorders. Alternatively spliced transcript variants have been described. [provided by RefSeq, May 2010].
* **UniProt Summary**: Catalyzes the first reaction in the catabolism of the essential branched chain amino acids leucine, isoleucine, and valine.
|Aminotran 4|
|leucine biosynthetic process|
|branched-chain amino acid biosynthetic process|
|valine biosynthetic process|
|L-isoleucine transaminase activity|
|L-valine transaminase activity|
|L-leucine transaminase activity|
|branched-chain-amino-acid transaminase activity|
|valine metabolic process|
|leucine metabolic process|
|branched-chain amino acid metabolic process|
|branched-chain amino acid catabolic process|
|alpha-amino acid biosynthetic process|
|cellular amino acid biosynthetic process|
|G1/S transition of mitotic cell cycle|
|cell cycle G1/S phase transition|
|cellular amino acid catabolic process|
|alpha-amino acid metabolic process|
|organic acid catabolic process|
|carboxylic acid catabolic process|
|mitotic cell cycle phase transition|
|cell cycle phase transition|
|carboxylic acid biosynthetic process|
|organic acid biosynthetic process|
|cellular amino acid metabolic process|
|small molecule catabolic process|
|small molecule biosynthetic process|
|mitotic cell cycle process|
|mitotic cell cycle|
|carboxylic acid metabolic process|
|cell cycle process|
|oxoacid metabolic process|
|organic acid metabolic process|
|organonitrogen compound catabolic process|
|identical protein binding|
|mitochondrion|
|cell cycle|
|organonitrogen compound biosynthetic process|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|-2.24|
|[[:results:exp436|Dynasore 7μM R08 exp436]]|-1.76|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 7594
* **Expression level (log2 read counts)**: 8.52
{{:chemogenomics:nalm6 dist.png?nolink |}}